| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Magna International Inc.
| TSE
|
MG
|
67.25
|
|
-0.47
(-0.69%)
| 15.66B
|
|
|
Magna International Inc. (Magna) is a diversified global automotive supplier. It
designs, develops and manufactures automotive systems, assemblies, ...
| |
| |
|
|
Mistras Group Inc
| NYSE
|
MG
|
21.30
|
|
+0.31
(1.48%)
| 600.55M
|
|
|
Mistras Group, Inc. (Mistras) is a global provider of technology-enabled asset
protection solutions used to evaluate the structural integrity of critical ...
| |
| |
|
|
AnGes MG, Inc.
| TYO
|
4563
|
268,000.00
|
|
-2,000.00
(-0.74%)
| 39.94B
|
|
|
AnGes MG, Inc. is mainly engaged in the development of genetic medicines. The
Company is segment the development of hepatocyte growth factor (HGF) genetic ...
| |
| |
|
|
MG International SA
| EPA
|
ALMGI
|
0.900
|
|
0.000
(0.00%)
| 3.87M
|
|
|
MG International SA is a France-based company that specializes in swimming pool
security and hygiene. The Company produces and sells a range of equipment ...
| |
| |
|
|
MG HOME CO., LTD.
| TYO
|
8891
|
101,900.00
|
|
0.00
(0.00%)
| 1.79B
|
|
|
MG HOME CO., LTD. is a Japan-based real estate company. The Company has two
business segments. The Condominium segment is engaged in the planning, ...
| |
| |
|
|
MG Biotherapeutics LLC
| Private
|
|
|
|
|
|
|
|
The two companies' joint venture, MG Biotherapeutics, was created in 2004 to
develop new treatments for heart attacks and other cardiovascular conditions.
| |
| |
|
|
ANADOLU E.BIR.M.G. TN 1
| FRA
|
EF4
|
23.00
|
|
0.00
(0.00%)
|
|
|
|
|
|
|
ANGES MG, INC.
| FRA
|
AJW
|
2,025.00
|
|
-3.52
(-0.17%)
|
|
|
|
|
|
|
INAV IS.FTSE/M.G.100 GBP
| INDEXDB
|
4MT5
|
15.47
|
|
-0.01
(-0.03%)
|
|
|
|
|
|
|
BMB MUSIC MG
| BOM
|
531420
|
1.92
|
|
0.00
(0.00%)
|
|
|
|
|
|
|
GlaxoSmithKline plc (ADR)
| NYSE
|
GSK
|
52.97
|
|
+0.24
(0.46%)
| 130.03B
|
|
|
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the
creation and discovery, development, manufacture and marketing of ...
| |
| |
|
|
UBS(I)ETF-SOL.G.C.MG ADDL
| FRA
|
UBU0
|
14.39
|
|
0.00
(0.00%)
|
|
|
|
|
|
|
GlaxoSmithKline plc
| LON
|
GSK
|
1,749.50
|
|
+7.50
(0.43%)
| 84.75B
|
|
|
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the
creation and discovery, development, manufacture and marketing of ...
| |
| |
|
|
Eisai Co., Ltd
| TYO
|
4523
|
4,185.00
|
|
+5.00
(0.12%)
| 1.19T
|
|
|
Eisai Co., Ltd. is mainly engaged in the manufacture and sale of pharmaceutical
products. The Company operates in two business segments.
| |
| |
|
|
UBS(I)ETF-SOL.G.C.MG IDDL
| FRA
|
UBUA
|
5,756.66
|
|
-3.87
(-0.07%)
|
|
|
|
|
|
|
Actavis Inc
| NYSE
|
ACT
|
127.23
|
|
-0.85
(-0.66%)
| 16.25B
|
|
|
Actavis, Inc. formerly Watson Pharmaceuticals, Inc., is a integrated global
specialty pharmaceutical company engaged in the development, manufacturing, ...
| |
| |
|
|
GLAXOSMITHKLINE PLC
| OTCMKTS
|
GLAXF
|
26.20
|
|
-0.27
(-1.02%)
| 129.90B
|
|
|
|
|
|
GlaxoSmithKline PLC
| FRA
|
GS7
|
20.49
|
|
+0.18
(0.90%)
|
|
|
|
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the
creation and discovery, development, manufacture and marketing of ...
| |
| |
|
|
ACTAVIS INC. DL-,0033
| FRA
|
WAP1
|
98.87
|
|
-2.88
(-2.83%)
|
|
|
|
|
|
|
GLAXOSMITHKLINE SP. ADR/2
| ETR
|
GS7A
|
39.90
|
|
-1.10
(-2.68%)
|
|
|
|
|
|
|
Show all 185 companies »
|
|
| Mutual Fund
| Symbol
| Nav
| Nav change
|
|
|
TD MGD AGGRESSIVE GROWTH PORT I
|
TDB011
| 10.95
|
+0.03
(0.27%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth with the added potential for earning a modest level of interest and ...
| |
| |
|
|
TD MGD BALANCED GROWTH PORT I
|
TDB008
| 11.86
|
+0.02
(0.17%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth while also providing the opportunity to earn some interest and dividend
...
| |
| |
|
|
TD MGD INCOME PORTFOLIO I
|
TDB001
| 11.11
|
+0.01
(0.09%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD MGD INC & MOD GROWTH PORT I
|
TDB006
| 11.83
|
+0.02
(0.17%)
|
|
|
The investment objective of the Portfolio is to generate a reasonable rate of
interest and dividend income while also providing the opportunity for moderate
...
| |
| |
|
|
HSBC Indian Equity Mgr
|
HKB2521
| 8.03
|
-0.24
(-2.93%)
|
|
|
The fundamental investment objective of this Fund is to provide long-term
capital growth by investing primarily in a diversified portfolio of investments
in ...
| |
| |
|
|
AGF Canadian Cnsrv Inflation Mgd Inc
|
AGF215
| 9.21
|
+0.01
(0.11%)
|
|
|
The investment objective is to provide high monthly income with safety of
capital through short-term bonds issued by Canadian governments and income ...
| |
| |
|
|
CI Select Income Adv Mgd Corp Cl A
|
CIG1331
| 11.38
|
+0.02
(0.18%)
|
|
|
The investment objective of this fund is to provide exposure to a diversified
portfolio of income-generating securities in a manner that is similar to ...
| |
| |
|
|
TD FUNDSMART MGD INCOME PORT I
|
TDB360
| 11.48
|
+0.01
(0.09%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD Mgd Income Portfolio T
|
TDB662
| 13.45
|
+0.01
(0.06%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD FUNDSMART MGD BALANCED GROWTH I
|
TDB362
| 11.60
|
+0.02
(0.17%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth while also providing the opportunity to earn some interest and dividend
...
| |
| |
|
|
TD Mgd Income Portfolio K
|
TDB616
| 13.72
|
+0.01
(0.07%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD Mgd Income Portfolio H
|
TDB733
| 13.47
|
+0.01
(0.07%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD MGD IDX AGG GROWTH PT - E
|
TDB853
| 11.33
|
+0.06
(0.53%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth with the added potential for earning a modest level of interest and ...
| |
| |
|
|
TD MGD IDX BAL GROWTH PORT - E
|
TDB852
| 10.80
|
+0.03
(0.28%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth while also providing the opportunity to earn some interest and dividend
...
| |
| |
|
|
TD MGD MAXIMUM EQUITY GROWTH PORT I
|
TDB334
| 10.00
|
+0.03
(0.30%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth by investing primarily in units of TD Mutual Funds with an emphasis on
...
| |
| |
|
|
TD MGD IDX MAX EQ GROWTH PORT - E
|
TDB854
| 10.76
|
+0.07
(0.65%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth.
| |
| |
|
|
TD MGD IDX INC PORT - E
|
TDB850
| 11.06
|
+0.01
(0.09%)
|
|
|
The investment objective of the Portfolio is to generate a moderate level of
income while preserving investment capital and liquidity and providing some ...
| |
| |
|
|
TD FUNDSMART MGD AGGRESSIVE GROWTH I
|
TDB363
| 10.67
|
+0.03
(0.28%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth with the added potential for earning a modest level of interest and ...
| |
| |
|
|
TD FUNDSMART MGD MAX EQUITY GROWTH P
|
TDB184
| 11.28
|
+0.05
(0.45%)
|
|
|
The investment objective of the Portfolio is to generate long-term capital
growth.
| |
| |
|
|
TD MGD IDX INC&MOD GROWTH PORT - E
|
TDB851
| 11.39
|
+0.02
(0.18%)
|
|
|
The investment objective of the Portfolio is to generate a reasonable rate of
interest and dividend income while also providing the opportunity for moderate
...
| |
| |
|
|
Show all 314 funds »
|
